The medical device industry is booming and shows no signs of slowing down. In 2022, the FDA (Federal Food and Drug Administration) will clear or approve over 1,000 medical devices. This is great news for patients who stand to benefit from the latest and greatest technology, but it can be tough for hospitals and doctors to keep up with all of the new devices on the market.
Here's a breakdown of some of the most anticipated otc medical devices that have already received FDA approval. Some
Read More
glucose data
Rimidi and ARKRAY Partner to Bring Glucose Data to the EHR
What You Should Know:
- In an effort to make blood glucose data more actionable for providers and patients alike, Rimidi, a leading clinical management platform announced its integration with the ARKRAY GLUCOCARD® Shine Connex Blood Glucose Monitoring System to Rimidi’s Platform.
- The integration enables providers to manage blood-glucose control more proactively within existing workflows, thus boosting patient adherence.
Blood Glucose Data Directly Embedded in EHR
Diabetes is the
Read More
Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids
A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.
The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More
Ultrahuman Secures $17.5M for Fitness Wearable Glucose Tracker
What You Should Know:
- Health tech startup Ultrahuman has raised $17.5 million in Series B funding as it sets out to re-invent fitness-tech via its glucose tracking wearable that helps people improve their diet and exercise. The series B funding came from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures, and Utsav Somani’s iSeed fund.
- Founded in 2020 by Mohit Kumar and Vatsal Singhal who were
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
5 Reasons Why Providers Need Electronic Support for Glycemic Management
It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death.
Insulin has been the most effective therapy for hyperglycemia since it was first created almost 100 years ago, but it can also be dangerous if not managed properly. In fact, nearly 50% of all
Read More
DreaMed Launches Virtual Diabetes Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine
What You Should Know:
- As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely.
- The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment.
- According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More
Validic Adds High-Frequency Data Support, Delivering Minute-to-Minute Readings From Wearables, Home Health Devices
- Validic has added support for high-frequency data, enabling organizations to receive standardized activity, heart rate, and blood glucose data at a rate up to one reading per minute.- The availability of these data for use in healthcare and wellness programs indicate an important shift toward more real-time, individualized interventions and coaching services.Validic, a Durham, NC-based provider of solutions for personal health data, today at HLTH 2019 announced the support of high-frequency
Read More
Omada Health Integrates With Abbot’s Freestyle Libre for People with Type 2 Diabetes
- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care.- As part of Omada’s expanded Type 2 diabetes offering, FreeStyle Libre will be the exclusive CGM delivered directly to participants’ doorsteps – expanding access to the technology for more people with diabetes.Abbott and Omada Health announced they are partnering to integrate Abbott's revolutionary FreeStyle
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
